H
Hans-Peter Hartung
Researcher at University of Düsseldorf
Publications - 88
Citations - 14386
Hans-Peter Hartung is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: Multiple sclerosis & Peripheral nervous system. The author has an hindex of 39, co-authored 88 publications receiving 13699 citations. Previous affiliations of Hans-Peter Hartung include University Hospital of Basel & Medical University of Vienna.
Papers
More filters
Journal ArticleDOI
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
W. Ian McDonald,A Compston,Gilles Edan,Donald E. Goodkin,Hans-Peter Hartung,Fred D. Lublin,Henry F. McFarland,Donald W. Paty,Chris H. Polman,Stephen C. Reingold,Magnhild Sandberg-Wollheim,William A. Sibley,Alan J. Thompson,Stanley van den Noort,Brian Y. Weinshenker,Jerry S. Wolinsky +15 more
TL;DR: The revised criteria facilitate the diagnosis of MS in patients with a variety of presentations, including “monosymptomatic” disease suggestive of MS, disease with a typical relapsing‐remitting course, and disease with insidious progression, without clear attacks and remissions.
Journal ArticleDOI
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.
Giancarlo Comi,Massimo Filippi,Frederik Barkhof,Luca Durelli,Gilles Edan,Oscar Fernandez,Hans-Peter Hartung,Pierrette A. Seeldrayers,Per Soelberg Sørensen,Marco Rovaris,Vittorio Martinelli,Otto R. Hommes +11 more
TL;DR: Interferon beta-1a treatment at an early stage of multiple sclerosis had significant positive effects on clinical and MRI outcomes.
Journal ArticleDOI
Chemotherapy-induced peripheral neuropathy.
TL;DR: A general predisposition for developing a chemotherapy-induced neuropathy has been observed in nerves previously damaged by diabetes mellitus, alcohol or inherited neuropathy and no drug is available to reliably prevent or cure chemotherapy- induced neuropathy.
Journal ArticleDOI
Electrophysiological classification of guillain-barré syndrome: Clinical associations and outcome
R. D. M. Hadden,David R. Cornblath,Richard A. C. Hughes,Jürgen Zielasek,Hans-Peter Hartung,K.V. Toyka,A. V. Swan +6 more
TL;DR: In this paper, electrophysiological and serological testing within 15 days of symptom onset on 369 patients with Guillain-Barre Syndrome (GBS) enrolled in a trial comparing plasma exchange, intravenous immunoglobulin, and both treatments.
Journal ArticleDOI
Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE).
Roland Bammer,Stephen L. Keeling,M. Augustin,Klaas P. Pruessmann,Roswitha Wolf,Rudolf Stollberger,Hans-Peter Hartung,Franz Fazekas +7 more
TL;DR: Because of the faster k‐space traversal, this novel technique is able to reduce typical EPI artifacts and increase spatial resolution while simultaneously remaining insensitive to bulk motion.